Sysmex Europe, Cytek Biosciences partner to expand clinical flow cytometry access in Europe

• Cytek Biosciences entered a strategic collaboration with Sysmex Europe to expand access to advanced clinical flow cytometry across more than a dozen European countries.
• Partnership targets clinical labs seeking faster, more standardized testing while supporting increasingly complex diagnostic requirements.
• Joint offering combines Sysmex routine flow cytometry and automated sample preparation with Cytek’s Northern Lights-CLC spectral flow cytometer for advanced multicolor analysis.
• Focus includes applications in leukemia, lymphoma, measurable residual disease assessment, positioned as an end-to-end workflow from sample prep to analysis.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytek Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609090830PRIMZONEFULLFEED9823419) on September 09, 2026, and is solely responsible for the information contained therein.